SNBL TR Division provides feasibility study for nasal drug delivery

FEASIBILITY STUDY

Test of Suitability for a Nasal Formulation

Do you have any existing drugs or compounds targeted for nasal delivery?
In order to readily assess suitability of existing drugs and new compounds for nasal delivery, Translational Research Division (TR) can provide you with quick, cost-effective, and validated feasibility studies: these studies consist of preparation for a nasal formulation using TR's own technology for and animal studies in non-human primates to enable accurate evaluation of nasal absorption.

TR has developed a non-clinical evaluation system to evaluate nasal drug absorption; this evaluation sytem enables the generation of high quality data through our extensive R&D experience with

. The evaluation system consists of

and original administration equipment and a non-human primate model which has a similar nasal cavity structure to that of humans. Through the results of both our pre-clinical and clinical studies using

for nasal granisetron (graph), the evaluation system has been verified as a useful tool to predict clinical data.
TR provides companies with feasibility studies using the evaluation system, so that companies are able to readily judge the suitability and advantages of targeted drugs / compounds for nasal delivery using

a leading company in nasal drug delivery